Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Thorac Cancer ; 14(26): 2687-2695, 2023 09.
Artigo em Inglês | MEDLINE | ID: mdl-37551918

RESUMO

BACKGROUND: Older patients tend to have decreased physical functions and more comorbidities than younger patients. At present, the best management for very elderly patients with lung cancer is not known. In this study, we aimed to investigate treatment and mortality risk of older adults with non-small cell cancer (NSCLC) in Taiwan. METHODS: This study analyzed data from the Taiwan Cancer Registry database. Patients aged ≥80 years with newly diagnosed NSCLC between 2010 and 2017 were included. Treatment options were categorized as curative, palliative, and no treatment. Patients were followed up until death or December 31, 2020. Univariable and multivariable Cox proportional hazards models were used to estimate mortality risk, and Kaplan-Meier survival curves were drawn. RESULTS: A total of 11 941 patients, aged ≥80 years, with newly diagnosed NSCLC between 2010 and 2017 were identified from the Taiwan Cancer Registry and followed up until 2020. The mean age was 84.4 ± 3.7 years old, and 7468 (62.54%) were men. The Kaplan-Meier survival curves showed significant differences across the three treatment options (log-rank p < 0.001). Results from multivariate Cox regression demonstrated that patients on palliative treatment (adjusted HR: 0.52, 95% CI: 0.48-0.56, p < 0.001) and curative treatment (adjusted HR: 0.45, 95% CI: 0.42-0.48, p < 0.001) had a significantly lower mortality risk than those with no treatment. The subgroup analyses stratified by cancer stages also showed consistent findings. CONCLUSION: Elderly patients with NSCLC had significantly decreased mortality risk when receiving curative or palliative treatment compared with those without treatment. In the future, further studies are warranted to investigate complications and quality of life of elderly patients with NSCLC during palliative or curative treatment.


Assuntos
Carcinoma Pulmonar de Células não Pequenas , Neoplasias Pulmonares , Masculino , Idoso , Humanos , Idoso de 80 Anos ou mais , Feminino , Carcinoma Pulmonar de Células não Pequenas/epidemiologia , Carcinoma Pulmonar de Células não Pequenas/terapia , Carcinoma Pulmonar de Células não Pequenas/diagnóstico , Estudos de Coortes , Taiwan/epidemiologia , Qualidade de Vida , Neoplasias Pulmonares/terapia
2.
Technol Health Care ; 27(S1): 109-121, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31045531

RESUMO

BACKGROUND: The morbidity of breast cancer has continuously achieved a global topicality. In particular, during the last decade several ten thousand female adults in Taiwan have been confirmed as breast cancer patients. OBJECTIVE: To predict the survival rate of breast cancer patients at various (0-IV) stages and provide efficient assessment of proposed radiotherapy for patients. METHODS: The prediction algorithm proposed is based on the revised hit and target model and implies the application of Taylor series expansion to the population-based survey dataset. The proposed algorithm features a specific function comprising a single simple exponential term exp⁡(-α⁢t) to imply the fundamental degradation of patient's health multiplied by an additional term P⁢(α⁢t), which specifies the recovery effect of a particular therapy. RESULTS: Its calculated values for breast cancer patients who undergone radiotherapy at different stages 0-IV were {0.0029, 0.0066, 0.0178, 0.0475, 0.1785} yr-1, respectively, while those for corresponding groups of patients with no radiotherapy were assessed as {0.0072, 0.0137, 0.0264, 0.0913, 0.2425} yr-1. CONCLUSIONS: The revised algorithm successfully interpreted the breast cancer patients' survival rate at stages 0-IV and evaluated the necessity of radiotherapy for patients at various stages as well.


Assuntos
Algoritmos , Neoplasias da Mama/radioterapia , Taxa de Sobrevida , Neoplasias da Mama/patologia , Neoplasias da Mama/cirurgia , Feminino , Humanos , Modelos Estatísticos , Taiwan
3.
Comput Assist Surg (Abingdon) ; 22(sup1): 70-78, 2017 12.
Artigo em Inglês | MEDLINE | ID: mdl-28922944

RESUMO

AIM: Coronary artery stenosis readings were predicted in this study on the basis of clinical data for patients with coronary heart diseases using the inverse problem algorithm. METHOD: Five factors, including age, BSA (body surface area), MAP (mean artery pressure), sugar AC (ante cibum), and LDL-C (low-density Lipoprotein-Cholesterol) were incorporated into a nonlinear first-order regression fit analysis to develop a prediction equation with sixteen terms derived via a revised inverse problem algorithm implemented through the STATISTICA default regression fit. The clinical data acquired from ninety-three coronary heart disease patients were first normalized to the same domain range of [-1 to +1], and then processed by the above algorithm to find the compromised solution of predicted coronary artery stenosis reading. The actual reading was obtained by weighting the stenosis of three major cardiac artery branches, namely, the left anterior descending artery (LAD) (wi 0.3), left circumflex artery (LCA) (wi 0.3), and right coronary artery (RCA) (wi 0.4). RESULT: The derived regression fit possessed the final loss function value Φ = 3.589 and correlation coefficient r2 = 0.892 with variance of 79.55%. Accordingly, forty-five patients with similar syndromes were analyzed to verify the prediction, which exhibited a high coincidence. The LDL-C factor was dominant for the prediction of the largest coefficient in the derived equation, whereas the age factor exhibited a minor contribution to the regression fit. The attempts to reduce the number of influence factors to 4, 3 or 2 for the model simplification yielded the results, whose low linearity and high loss function values reflected their inappropriate setting. CONCLUSION: The algorithm proved to be an effective technique for prediction of the potential diagnosis in the medical field.


Assuntos
Algoritmos , Angiografia Coronária/métodos , Estenose Coronária/diagnóstico , Modelos Teóricos , Idoso , Pressão Arterial/fisiologia , Superfície Corporal , Cateterismo Cardíaco/métodos , LDL-Colesterol/sangue , Angiografia por Tomografia Computadorizada/métodos , Doença das Coronárias/diagnóstico , Estenose Coronária/diagnóstico por imagem , Feminino , Humanos , Modelos Lineares , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Análise de Regressão , Fatores de Risco , Estudos de Amostragem
4.
Hum Genomics ; 5(6): 569-76, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22155604

RESUMO

The genes encoding the enzymes for metabolising alcohol dehydrogenase 1B (ADH1B) and aldehyde dehydrogenase 2 (ALDH2) - exhibit genetic polymorphism and ethnic variations. Although the ALDH2*2 variant allele has been widely accepted as protecting against the development of alcoholism in Asians, the association of the ADH1B*2 variant allele with drinking behaviour remains inconclusive. The goal of this study was to determine whether the polymorphic ADH1B and ALDH2 genes are associated with stroke in male Han Chinese with high alcohol consumption. Sixty-five stroke patients with a history of heavy drinking (HDS) and 83 stroke patients without such a history (NHDS) were recruited for analysis of the ADH1B and ALDH2 genotypes from the stroke registry in the Tri-Service General Hospital, Taipei, Taiwan, between January 2000 and December 2001. The allelotypes of ADH1B and ALDH2 were determined using the polymerase chain reaction-restriction fragment length polymorphism method. The HDS patients (3 per cent) showed a significantly lower ALDH2*2 allele frequency than NHDS patients (27 per cent) (p < 0.001). After controlling for age, patients with HDS were associated with a significantly higher occurrence of cigarette smoking (p < 0.01) and liver dysfunction (p < 0.01). Multiple logistic regression analyses revealed that the ALDH2*2 variant allele was an independent variable exhibiting strong protection (odds ratio 0.072; 95 per cent confidence interval 0.02-0.26) against HDS after adjustment for hypertension, diabetes mellitus, smoking status and liver dysfunction. By contrast, allelic variations in ADH1B exerted no significant effect on HDS. The present study indicated that, unlike ALDH2*2, ADH1B*2 appears not to be a significant negative risk factor for high alcohol consumption in male Han Chinese with stroke.


Assuntos
Álcool Desidrogenase/genética , Consumo de Bebidas Alcoólicas/efeitos adversos , Aldeído Desidrogenase/genética , Polimorfismo Genético/genética , Acidente Vascular Cerebral/induzido quimicamente , Acidente Vascular Cerebral/genética , Adulto , Idoso , Idoso de 80 Anos ou mais , Aldeído-Desidrogenase Mitocondrial , Estudos de Casos e Controles , China , Seguimentos , Genótipo , Humanos , Masculino , Pessoa de Meia-Idade , Prognóstico , Fatores de Risco
5.
Cerebrovasc Dis ; 23(4): 309-14, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17204834

RESUMO

BACKGROUND: Epidemiological evidence suggests that heavy alcohol consumption increases the risk for either stroke or liver disease. The goal of this study was to determine whether heavy drinkers with mild liver disorder (MLD) are at risk of hemorrhagic stroke. METHODS: All of the 524 patients recruited were males with a first-ever acute stroke and were consecutively admitted to the Tri-Service General Hospital between January 2000 and December 2001. The risk factors, liver function, stroke subtypes, and hemostatic factors were assessed among 68 patients defined as heavy drinker stroke (HDS) and 456 patients as non-heavy drinker stroke (NHDS). RESULTS: HDS patients had a significantly higher incidence of hemorrhagic stroke than NHDS patients. HDS patients were also associated with significantly higher occurrence of cigarette smoking, hyperuricemia, liver dysfunction, and significantly lower platelet counts. HDS patients with MLD were more likely to have hemorrhagic stroke (76.5%) than HDS patients without MLD (33.3%) and NHDS patients with (40.3%) or without (26.7%) MLD. HDS patients with MLD also exhibited a significantly higher glutamic oxaloacetic transaminase/glutamic pyruvic transaminase ratio (2.0 +/- 1.2) and lower platelet number (185,000 +/- 85,000 per microl) when compared with HDS patients without MLD (1.4 +/- 0.5; 206,000 +/- 59,000 per microl) and NHDS patients with (1.1 +/- 1.0; 256,000 +/- 97,000 per microl) or without (1.4 +/- 0.7; 216,000 +/- 68,000 per microl) MLD. CONCLUSIONS: HDS patients with MLD are at higher risk for hemorrhagic stroke in part due to the changes in hemostatic factors, although other factors may also contribute to hemorrhagic stroke.


Assuntos
Alcoolismo/complicações , Povo Asiático/estatística & dados numéricos , Hemorragia Cerebral/etiologia , Hepatopatias Alcoólicas/complicações , Acidente Vascular Cerebral/etiologia , Hemorragia Subaracnóidea/etiologia , Doença Aguda , Adulto , Idoso , Idoso de 80 Anos ou mais , Alanina Transaminase/sangue , Alcoolismo/sangue , Alcoolismo/epidemiologia , Aspartato Aminotransferases/sangue , Hemorragia Cerebral/sangue , Hemorragia Cerebral/complicações , Hemorragia Cerebral/epidemiologia , China/epidemiologia , Humanos , Hiperuricemia/complicações , Incidência , Hepatopatias Alcoólicas/sangue , Hepatopatias Alcoólicas/epidemiologia , Hepatopatias Alcoólicas/etiologia , Masculino , Pessoa de Meia-Idade , Razão de Chances , Contagem de Plaquetas , Estudos Prospectivos , Medição de Risco , Fatores de Risco , Índice de Gravidade de Doença , Fumar/efeitos adversos , Acidente Vascular Cerebral/sangue , Acidente Vascular Cerebral/epidemiologia , Hemorragia Subaracnóidea/sangue , Hemorragia Subaracnóidea/complicações , Hemorragia Subaracnóidea/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA